Main > ONCOLOGY (**) > Ovarian Cancer MET R *** > Treatment > Co: CH. N. Brand TopoTecan Inj.
Co: CH. N. Brand TopoTecan Inj.'s subsections
(*) USA Initial Approval: 1996
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2007. 11.13
Patent>USA Expiration: 2010. 05.28
TradeMark
TradeMark Web-Site
Co: CH. N. Brand TopoTecan Inj.'s products
This section has no products